Skip to main content

Table 1 Clinical characteristics of Heart Failure patients based on Preserved of reduced ejection fraction

From: Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study

Variable Total patients (n = 311) LVEF ≥ 50% (n = 164) LVEF < 50% (n = 147) P value
Women, n (%) 217 (69.77) 125 (76.22) 92 (62.59) 0.009
Age, Years (mean ± SD) 53.58 (±16.902) 54.20 (±16.587) 52.88 (±17.246) 0.496
Anemia, n (%) 118 (37.94) 65 (39.63) 53 (36.05) 0.516
AF, n (%) 79 (25.41) 47 (28.66) 32 (21.77) 0.163
DM, n (%) 4 (1.29) 2 (1.22) 2 (1.36) 0.912
Hypertension, n (%) 97 (0.312) 56 (34.15) 41 (27.89) 0.235
Heart Rate ( mean ± SD) 92.88 (±19.166) 95.60 (±21.177) 89.93 (±16.287) 0.009
Systolic BP 122.75 (±24.231) 125.06 (±26.911) 120.18 (±20.651) 0.072
NYHA Functional Class     0.274
Class III, n (%) 82 (26.37) 39 (23.78) 43 (29.25)  
Class IV, n (%) 229 (73.63) 125 (76.22) 104 (70.75)  
Etiology
 IHD, n (%) 49 (15.76) 18 (10.98) 31 (21.09) 0.015
 HHD, n (%) 50 (16.08) 33 (20.12) 17 (11.56) 0.040
 VHD, n (%) 127 (40.84) 77 (46.95) 50 (34.01) 0.020
 DCMP, n (%) 39 (12.54) 7 (4.27) 32 (21.77) <0.001
 Cor pulmonale, n (%) 14 (4.50) 9 (5.48) 5 (3.40) 0.376
 Others, n (%) 32 (10.29) 20 (12.20) 12 (8.16) 0.243
  1. AF atrial fibrillation, BP blood pressure, DCMP dilated cardiomyopathy DM diabetes mellitus, HHD hypertensive heart disease, IHD ischemic heart disease, NYHA New York Heart Association, SD standard deviation